Page last updated: 2024-09-04

docetaxel anhydrous and Lymphoma, Large B-Cell, Diffuse

docetaxel anhydrous has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, J; Li, H; Li, Y; Ouyang, J; Wang, J; Wu, L; Zhang, Z; Zuo, L1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma.
    Anti-cancer drugs, 2014, Volume: 25, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lymphoma, Large B-Cell, Diffuse; Paclitaxel; Taxoids; Tumor Cells, Cultured

2014
chemdatabank.com